IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PETRALIA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.800
NA - Nord America 6.466
AS - Asia 6.318
SA - Sud America 662
AF - Africa 124
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.261
DE - Germania 4.321
SG - Singapore 1.924
CN - Cina 1.865
IT - Italia 1.693
GB - Regno Unito 1.293
HK - Hong Kong 693
SE - Svezia 644
RU - Federazione Russa 501
BR - Brasile 497
VN - Vietnam 403
BD - Bangladesh 396
FR - Francia 324
IN - India 273
NL - Olanda 218
IE - Irlanda 184
FI - Finlandia 153
CA - Canada 129
TR - Turchia 112
KR - Corea 109
ID - Indonesia 108
JP - Giappone 104
UA - Ucraina 81
PH - Filippine 74
DK - Danimarca 73
AU - Australia 56
ES - Italia 56
TW - Taiwan 50
AR - Argentina 49
BE - Belgio 46
AT - Austria 43
PL - Polonia 41
CI - Costa d'Avorio 37
EU - Europa 37
IQ - Iraq 32
CO - Colombia 28
CH - Svizzera 27
MX - Messico 26
EC - Ecuador 25
NO - Norvegia 20
ZA - Sudafrica 20
PE - Perù 19
IR - Iran 18
CL - Cile 17
MA - Marocco 17
PK - Pakistan 17
AE - Emirati Arabi Uniti 15
GR - Grecia 15
MY - Malesia 15
SA - Arabia Saudita 15
KE - Kenya 14
UZ - Uzbekistan 12
VE - Venezuela 12
RO - Romania 11
BG - Bulgaria 9
EG - Egitto 9
JM - Giamaica 9
NP - Nepal 9
TH - Thailandia 9
IL - Israele 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
JO - Giordania 7
KZ - Kazakistan 7
PT - Portogallo 7
AZ - Azerbaigian 6
NG - Nigeria 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
HN - Honduras 5
LB - Libano 5
LU - Lussemburgo 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
BY - Bielorussia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LT - Lituania 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
MN - Mongolia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SM - San Marino 3
AD - Andorra 2
AO - Angola 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
PR - Porto Rico 2
Totale 23.441
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 3.925
Singapore 1.114
Southend 1.041
Ashburn 775
Hong Kong 609
San Jose 437
Milan 430
Chandler 428
Dallas 400
Beijing 339
Fairfield 279
Council Bluffs 258
Seattle 245
Los Angeles 200
Princeton 197
Wilmington 181
Dublin 179
Hefei 169
New York 161
Santa Clara 136
Rome 135
Dearborn 129
Houston 124
Woodbridge 119
Ann Arbor 118
Bengaluru 112
Lauterbourg 109
Ho Chi Minh City 108
Hanoi 99
Buffalo 98
Cambridge 98
Munich 94
Moscow 91
Guangzhou 87
Jakarta 86
Nanjing 84
Boardman 74
Helsinki 73
Shanghai 73
Phoenix 66
Des Moines 65
Columbus 58
Tokyo 58
Jacksonville 50
Jinan 46
Mountain View 45
São Paulo 45
Toronto 43
Cangzhou 42
Redmond 42
Florence 41
Turin 41
Naples 40
The Dalles 40
Brussels 39
Redwood City 38
Abidjan 37
Chicago 37
Berlin 36
Istanbul 34
London 32
Seoul 32
Nuremberg 30
Shenyang 28
Changsha 27
Hangzhou 26
Tianjin 25
Sakarya 23
Sydney 23
Central District 22
Silver Spring 22
Washington 22
Bologna 21
Hyderabad 21
Madrid 21
Shenzhen 21
Turku 21
Amsterdam 20
Bogotá 20
Orem 20
Dong Ket 19
Lappeenranta 19
Montreal 19
Andover 18
Atlanta 18
Bari 18
Eitensheim 17
San Diego 17
Serra 17
Warsaw 17
Wuhan 17
Haiphong 16
Oslo 16
Taipei 16
Athens 15
Genoa 15
Medford 15
Nanchang 15
Catania 14
Chennai 14
Totale 15.166
Salva come PNG Salva come JPEG
Nome #
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 474
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 422
Whole-body magnetic resonance imaging: Technique, guidelines and key applications 397
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 392
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels 365
Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: Review and recommendations 349
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 343
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 341
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy 320
Automatic Segmentation with Deep Learning in Radiotherapy 318
Effects of sex and age on fat fraction, diffusion-weighted image signal intensity and apparent diffusion coefficient in the bone marrow of asymptomatic individuals: A cross-sectional whole-body mri study 311
Whole-body magnetic resonance imaging (WB-MRI) in oncology : recommendations and key uses 307
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 295
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 293
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 292
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 292
US-guided transcutaneous tru-cut biopsy of laryngo-hypopharyngeal lesions 288
High-performance prediction models for prostate cancer radiomics 287
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies : Time to Improve Radiologists’ Training Program? 284
METastasis Reporting and Data System for Prostate Cancer : Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer 278
Small colorectal cystic metastases to the liver : still a diagnostic dilemma? A report of a case and a review of the literature 266
Sarcoidosis with bone involvement mimicking metastatic disease at 18F-FDG PET/CT : Problem solving by diffusion whole-body MRI 264
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer 260
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 260
Long survival in a patient with brain metastases from breast cancer 259
Anterior prostatic tumours are difficult to diagnose without MRI 258
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging 254
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 252
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 250
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 247
Mixup (Sample Pairing) Can Improve the Performance of Deep Segmentation Networks 246
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 245
Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients 244
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 244
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling 243
Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma 238
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 237
Cognitive alterations and brain functional changes following chemotherapy treatment in breast cancer patients: A systematic review on resting-state fMRI studies 236
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 234
Rationale for Modernising Imaging in Advanced Prostate Cancer 229
Quality assurance for automatically generated contours with additional deep learning 224
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 223
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 222
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 217
Contrast-enhanced ultrasound sonography optimises the assessment of lymph nodes in oncology 216
Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study 215
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy 213
Is whole-body magnetic resonance imaging a source of anxiety in oncological patients? 211
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial 210
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 208
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 204
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion : a plan comparison 203
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literature 199
Quantification of Variability in Breath-hold Perfusion CT of Hepatocellular Carcinoma : A Step toward Clinical Use 199
CT perfusion in oncology: how to do it 198
Surgical damage control treatment of a large retroperitoneal liposarcoma encasing a horseshoe kidney 191
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer : a review 191
The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases: A case report 191
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging 190
DCE-MRI and DWI integration for breast lesions assessment and heterogeneity quantification 190
CT perfusion in solid-body tumours. Part I: technical issues 189
Investigating cancer patient acceptance of Whole Body MRI 188
Intraobserver and interobserver variability in the calculation of apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance imaging (DW-MRI) of breast tumours 187
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis 186
Whole-body diffusion-weighted imaging : is it all we need for detecting metastases in melanoma patients? 183
Perfusion CT in solid body-tumours. Part II: Clinical applications and future development 181
[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning 180
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer 179
Value Attribution in the Decision to Use of Whole Body MRI for Early Cancer Diagnosis 178
Psychological characteristics and satisfaction for the whole-body MRI in cancer screening 177
Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study 175
Stadiazione locale del tumore del retto 172
Salvage therapy of small volume prostate cancer nodal failures : a review of the literature 171
Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response 171
A Phase 3 Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperativane Surgical Margins: A Clinical Trial Protocol 170
CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma : initial experience 170
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer 169
Extramedullary myeloid sarcoma of the breast 168
Observations Regarding the Detection of Abnormal Findings Following a Cancer Screening Whole‐Body MRI in Asymptomatic Subjects: The Psychological Consequences and the Role of Personality Traits Over Time 166
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time 165
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models 165
Pre-operative radiochemotherapy with raltitrexed for resectable locally-advanced rectal cancer : a phase II study 160
Baseline Multiparametric MRI for Selection of Prostate Cancer Patients Suitable for Active Surveillance : Which Features Matter? 159
Erratum: Small colorectal cystic metastases to the liver: Still a diagnostic dilemma? A report of a case and a review of the literature 158
Uro-oncologic patient management during the COVID-19 pandemic: Survey findings from an Italian oncologic hub 158
Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer 154
Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion 154
DW-MRI of the urogenital tract: Applications in oncology 152
Effects of MRI image normalization techniques in prostate cancer radiomics 150
Whole body MRI for systemic staging of breast cancer in pregnant women 149
Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer 148
Risk Assessment and Radiomics Analysis in Magnetic Resonance Imaging of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) 147
Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume 139
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies 134
Tumors of the gastro-intestinal tract part A: Rectal cancer 131
Semi-automated Segmentation of Bone Metastases from Whole-Body MRI: Reproducibility of Apparent Diffusion Coefficient Measurements 129
Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation? 128
Sclerosing angiomatoid nodular transformation of the spleen during pregnancy : diagnostic challenges and clinical management 128
Magnetic Resonance Imaging before Prostate Biopsy : Time to Talk 128
Local Staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection 127
Totale 22.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 0 0 0 0 0 0 64
2021/20221.429 82 61 91 91 117 98 73 70 164 148 136 298
2022/20231.865 284 202 158 164 152 315 63 138 180 33 119 57
2023/20243.763 62 71 80 73 260 152 573 524 275 499 594 600
2024/20254.523 588 546 484 440 264 215 140 359 189 304 383 611
2025/20268.171 777 644 835 605 726 434 1.068 364 839 555 1.129 195
Totale 24.247